电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

VEGFR2/CD309 Protein (glycosylated, Monomer, Soluble)

VEGFR2 宿主: 人 宿主: Insect Cells Recombinant > 95 % by SDS-PAGE Active
产品编号 ABIN1589573
发货至: 中国
  • 抗原 See all VEGFR2/CD309 (VEGFR2) 蛋白
    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
    蛋白类型
    Recombinant
    生物活性
    Active
    产品特性
    glycosylated, Monomer, Soluble
    宿主
    • 24
    • 6
    • 3
    • 2
    • 1
    资源
    • 19
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Insect Cells
    原理
    VEGFR-2/KDR (D7), soluble
    序列
    ASVGLPSVSL DLPRLSIQKD ILTIKANTTL QITCRGQRDL DWLWPNNQSG SEQRVEVTEC SDGLFCKTLT IPKVIGNDTG AYKCFYRETD LASVIYVYVQ DYRSPFIASV SDQHGVVYIT ENKNKTVVIP CLGSISNLNV SLCARYPEKR FVPDGNRISW DSKKGFTIPS YMISYAGMVF CEAKINDESY QSIMYIVVVV GYRIYDVVLS PSHGIELSVG EKLVLNCTAR TELNVGIDFN WEYPSSKHQH KKLVNRDLKT QSGSEMKKFL STLTIDGVTR SDQGLYTCAA SSGLMTKKNS TFVRVHEKPF VAFGSGMESL VEATVGERVR IPAKYLGYPP PEIKWYKNGI PLESNHTIKA GHVLTIMEVS ERDTGNYTVI LTNPISKEKQ SHVVSLVVYV PPQIGEKSLI SPVDSYQYGT TQTLTCTVYA IPPPHHIHWY WQLEEECANE PSQAVSVTNP YPCEEWRSVE DFQGGNKIEV NKNQFALIEG KNKTVSTLVI QAANVSALYK CEAVNKVGRG ERVISFHVTR GPEITLQPDM QPTEQESVSL WCTADRSTFE NLTWYKLGPQ PLPIHVGELP TPVCKNLDTL WKLNATMFSN STNDILIMEL KNASLQDQGD YVCLAQDRKT KKRHCVVRQL TVLERVAPTI TGNLENQTTS IGESIEVSCT ASGNPPPQIM WFKDNETLVE DSGIVLKDGN RNLTIRRVRK EDEGLYTCQA CSVLGCAKVE AFFIIEGA
    特异性
    Chromosomal location:4q11-q12
    产品特性
    Length (aa):738
    纯度
    > 95 % by SDS-PAGE
    Top Product
    Discover our top product VEGFR2 蛋白
  • 想要此Protein的其他选项吗?

    !
    探索我们的预定义定制蛋白和定制蛋白服务!

    您的项目需要进一步定制吗?联系我们,了解我们的定制蛋白解决方案

  • 应用备注
    Measured by its ability to inhibit the VEGF165-induced proliferation in human umbilical vein endothelial (HUVE) cells.
    说明

    Soluble Receptors

    限制
    仅限研究用
  • 状态
    Lyophilized
    溶解方式
    The lyophilized human sKDR is soluble in water and most aqueous buffers, it should be reconstituted in water or PBS to a concentration of not lower than 100 μg/mL.
    缓冲液
    25 mM MES, 100 mM NaCl, pH 5.5
    注意事项
    Avoid repeated freeze-thaw cycles.
    储存条件
    4 °C,-20 °C,-80 °C
    储存方法
    The material is stable for greater than six months at -20° C to -70° C. After the first thawing it is recommended to aliquote the material, because repeated freeze-thaw cycles will decrease the activity. Store at 4°C not longer than 2 days. Avoid repeated freeze-thaw cycles.
    有效期
    6 months
  • 抗原
    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
    别名
    VEGFR-2/KDR (VEGFR2 产品)
    背景
    Recombinant Human soluble Endothelial Growth Factor Receptor-2 (sKDR(D7)) is produced as a non-chimeric protein in a monomeric form. The soluble receptor protein consists of all 7 extracellular domains, which contain all the information necessary for high affinity ligand binding. The receptor monomers have a mass of approximately 116 kDa.Endothelial cells express three different vascular endothelial growth factor (VEGF) receptors, belonging to the family of receptor tyrosine kinases (RTKs). They are named VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1), VEGFR-3 (Flt-4). Their expression is almost exclusively restricted to endothelial cells, but VEGFR-1 can also be found on monocytes. All VEGF-receptors have seven immunoglobulin-like extracellular domains, a single transmembrane region and an intracellular split tyrosine kinase domain. VEGFR-2 has a lower affinity for VEGF than the Flt-1 receptor, but a higher signaling activity. Mitogenic activity in endothelial cells is mainly mediated by VEGFR-2 leading to their proliferation. The binding of VEGF165 to VEGFR-2 is dependent on heparin.
    Synonyms: soluble vascular endothelial growth factor receptor-2 , soluble CD309, soluble VEGF receptor-2, sKDR
    分子量
    116.0 kDa
    基因ID
    3791
    NCBI登录号
    NM_002253, NP_002244
    UniProt
    P35968
    途径
    RTK signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
You are here:
Chat with us!